Xenon Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XENE research report →
About the company
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada.
- CEO
- Andrea DiFabio
- IPO
- 2014
- Employees
- 316
- HQ
- Burnaby, BC, CA
Price Chart
- Market Cap
- $4.81B
- P/E
- -12.97
- P/S
- 0.00
- P/B
- 3.98
- EV/EBITDA
- -10.71
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -49.23%
- ROIC
- -30.44%
- Revenue
- $7.50M · 0.00%
- Net Income
- $-345,910,000 · -47.62%
- EPS
- $-4.36 · -44.85%
- Op Income
- $-373,070,000
- FCF YoY
- -51.75%
- 52W High
- $63.95
- 52W Low
- $30.00
- 50D MA
- $55.05
- 200D MA
- $47.37
- Beta
- 0.61
- Avg Volume
- 1.29M
Get TickerSpark's AI analysis on XENE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 5, 26 | PATOU GARY | sell | 1,322 |
| Jun 5, 26 | Cannon Gillian | sell | 1,190 |
| Jun 1, 26 | PATOU GARY | other | 2,645 |
| Jun 3, 26 | PATOU GARY | other | 10,507 |
| Jun 3, 26 | PATOU GARY | other | 1,593 |
| Jun 1, 26 | PATOU GARY | other | 2,645 |
| Jun 3, 26 | Machado Patrick | other | 10,507 |
| Jun 1, 26 | Machado Patrick | other | 2,645 |
| Jun 3, 26 | Machado Patrick | other | 1,593 |
| Jun 1, 26 | Machado Patrick | other | 2,645 |
Our XENE coverage
Recent articles, reports, and earnings notes.
No research on XENE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XENE report →Similar companies
Peers in the same neighborhood.